SecBot SecBot

TMCI

TREACE MEDICAL CONCEPTS, INC.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. FL· CIK 0001630627 Healthcare & Medical Devices
$4.44 +0.02 (+0.45%)
Nov 17 4:00 PM ET · prev $4.42
Market cap
$289.8M
Micro cap
Consensus
Hold
10% Buy or better · 10 analysts
Median target
$6.50
+46% · range $5.00–7.00
1 year
+59.1%
from $2.79 · Nov 18
30 days
+14.4%
from $3.88
52-week range
$1.20–5.34
−17% from high · low Mar 30
Avg volume 20D
348.6K
Nov 9 spike 1.09M
Short interest
1.79M
≈2.7% of shares · −6.9%
Days to cover
8.7
at average volume
Insider net
+$1.5M
1 buyer · 0 sellers · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
11
analyzed by SecBot
SecBot read MIXED 5 reports · 90 days
Balance 1 bearish · 0 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 4/5

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $1.5M at an average $3.21. No open-market sales. Price is 38% above their cost.

  • InstitutionsBEARISH

    Q3 2026: 8 added (0 new), 20 trimmed or exited.

  • AnalystsMIXED

    1 of 10 rate it Buy or better. Every target is above the price.

  • EstimatesFALLING

    Current-quarter EPS estimate −$0.080 → −$0.110 over 90 days. 1 up, 0 down in 30 days.

  • Short sellersSTEADY

    Short interest −6.9% to 1.79M shares. 8.7 days to cover, ≈2.7% of shares.

  • TrendUPTREND

    1% above its 50-day average. New closing high $5.34 on Nov 12.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
ROYAL BANK OF CANADANEAR_EXIT70Not reported
MILLENNIUM MANAGEMENT LLCADD1,246,800$5.5M
D. E. Shaw & Co., Inc.ADD791,389$3.5M
AQR CAPITAL MANAGEMENT LLCTRIM518,583$2.3M
SUSQUEHANNA INTERNATIONAL GROUP, LLPADD329,178$1.5M
CITADEL ADVISORS LLCTRIM287,955$1.3M
MORGAN STANLEYTRIM141,104$626.5K
Jain Global LLCTRIM139,017$617.2K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

10 analysts
Hold 10% rate it Buy or better
Strong Buy0Buy1Hold5Sell2Strong Sell2
12-month targets · 3 analysts

Price is below the lowest target. Median implies +46%.Targets as of Nov 18, 2026.

Recent actions
DateFirmActionRating
Nov 9, 2026Stifel
UPGRADE
UPGRADEBuy
Aug 10, 2026Truist Securities
MAINTAIN
MAINTAINHold
Jul 16, 2026Truist Securities
MAINTAIN
MAINTAINHold

Insider ledger

Form 4
$1.5M
bought · 1 insider
$0
sold · 0 insiders
+38.4%
vs their $3.21 cost
DateInsiderTypeValue
Oct 24, 2026
Scanlan Sean F.
Chief Innovation Officer
Oct 24, 2026
TAX W/H207 sh
Sep 30, 2026
Elder Scot Michael
Chief Legl & Comp Off, CorpSec
Sep 30, 2026
TAX W/H25,457 sh
Aug 24, 2026
Treace John T.
Chief Executive Officer
Aug 24, 2026
BUY$47.7K
Aug 21, 2026
Treace John T.
Chief Executive Officer
Aug 21, 2026
BUY$21.7K
Aug 20, 2026
Treace John T.
Chief Executive Officer
Aug 20, 2026
BUY$177.2K
Aug 9, 2026
Scanlan Sean F.
Chief Innovation Officer
Aug 9, 2026
TAX W/H9,814 sh
Aug 9, 2026
Hair Mark
Chief Financial Officer
Aug 9, 2026
TAX W/H37,102 sh
Aug 9, 2026
Elder Scot Michael
Chief Legl & Comp Off, CorpSec
Aug 9, 2026
TAX W/H16,253 sh

Earnings setup

Estimates
−$0.11
EPS estimate, this quarter
−38%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.11-$0.11–-$0.11-22.2%$67.2M
Next Q-$0.27-$0.29–-$0.26-10.2%$50.6M
Current FY-$0.81-$0.85–-$0.80+4.6%$208.0M
Next FY-$0.76-$0.79–-$0.73+1.9%$220.7M

Short side

FINRA· Oct 30, 2026
1,791,040
shares short
-6.9%
vs prior settlement
8.7
days to cover
≈2.7%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
Armistice Capital filed a new Schedule 13G disclosing a 9.79% passive stake in Treace Medical Concepts as of September…
SC 13G · Impact 4/10
Nov 16, 2026 SEC
Armistice Capital filed an amended Schedule 13G disclosing a 1.96% passive stake in Treace Medical Concepts as of…
SC 13G/A · Impact 4/10
Nov 12, 2026 SEC
The court issued a Markman claim construction ruling in Treace Medical's patent infringement suit against Stryker and…
COURT-RULING · Impact 4/10
Nov 12, 2026 Event
TREACE MEDICAL CONCEPTS, INC. v. STRYKER CORPORATION et al
Court ruling (njd). Docket: 2:24-cv-09763
Nov 6, 2026 Earnings
Treace Medical Concepts Reports Third Quarter 2026 Financial Results
Achieved double digit procedure volume growth in the third quarter Achieved double digit procedure v
Oct 24, 2026 Insider
Scanlan Sean F. surrendered for taxes 207 shares
Chief Innovation Officer
Sep 30, 2026 Insider
Elder Scot Michael surrendered for taxes 25,457 shares
Chief Legl & Comp Off, CorpSec
Sep 30, 2026 Inst.
ROYAL BANK OF CANADA · NEAR_EXIT
70 shares
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

11 filings · 0 bullish · 3 bearish · 2 mixed · 6 neutral
All TMCI filing & press-release reports (11)